PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic
  • Insights From Technical Analysis

Insights From Technical Analysis

Clarity Pharmaceuticals (ASX: CU6)

Clarity Pharmaceuticals (ASX: CU6) Shares Edge Higher After Investors React to Recent Price Swing

May 23, 2026
Proactive Equities Team

Clarity Pharmaceuticals (ASX: CU6) has seen renewed share price volatility as investors react to clinical updates and broader ASX healthcare swings. Despite pullbacks, interest in its radiopharmaceutical pipeline remains, especially SAR-bisPSMA. The company remains unprofitable, with valuation driven by trial progress and long-term oncology potential rather than current earnings.

AnteoTech (ASX: ADO)

AnteoTech (ASX: ADO) Rockets Higher as Battery Tech Breakthrough Ignites Massive Share Price Surge

May 23, 2026
Proactive Equities Team

AnteoTech (ASX: ADO) surged over 46% after independent validation of its Ultranode™ 95 silicon anode technology in commercial battery cells, boosting energy density. The breakthrough reignited investor interest in the speculative micro-cap amid hopes of future battery partnerships.

PolyNovo (ASX: PNV)

PolyNovo (ASX: PNV): Our Bottoming Thesis Confirmed by a Breakout Move

May 21, 2026
Proactive Equities Team

PolyNovo (ASX: PNV) is an advanced wound care company whose NovoSorb platform drives strong U.S.-led growth. After the March weakness from leadership changes, improving revenues and a technical breakout above the trend signal a potential bottom and renewed bullish momentum.

Nyrada (ASX: NYR)

Nyrada Inc. (ASX: NYR): Shares Suddenly Return to Traders' Radar Following Sharp Price Movement

May 21, 2026
Proactive Equities Team

Nyrada (ASX: NYR) shares have seen sharp volatility as traders react to its Xolatryp clinical progress and Phase IIa plans. Despite strong preclinical results and early trial safety data, the stock remains speculative, driven by momentum trading, retail interest, and upcoming biotech milestones.

Aristocrat Leisure (ASX: ALL)

Aristocrat Leisure (ASX: ALL): Strong Results Spark Re-Rating—But Can Growth Continue?

May 20, 2026
Proactive Equities Team

Aristocrat Leisure is a global gaming company delivering strong HY26 earnings growth and driving a share price re-rating, supported by buybacks and land-based strength, while investors remain cautious about whether digital segment growth can sustain long-term momentum.

Pacific Edge (ASX: PEB)

Pacific Edge (ASX: PEB): Testing Critical Resistance, Breakout or Reversal Ahead?

May 19, 2026
Proactive Equities Team

Pacific Edge (ASX: PEB) tests critical resistance near 0.240 after surging on draft Medicare coverage, a 75% increase in reimbursement rates, and a NZ$25.4 million capital raise. Strong volume supports the rally, but RSI near 70 warns of potential pullback risk.

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...414243...57
Page 42 of 57